Cargando…
Vaccination Against SARS-CoV-2 for Myeloma Patients: Do We Need a Booster Dose and How Frequent?
Patients with multiple myeloma (MM) are at increased risk for severe COVID-19 disease, hospitalization and death. In this context, it is essential to maintain an adequate immune profile. A third (first booster) dose has been offered with priority to patients with MM due to their immunocompromised st...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Editora Ltda.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529930/ http://dx.doi.org/10.1016/j.htct.2022.09.1191 |